MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$5,681K
EPS
-$0.06
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-12-31
2025-09-30
2025-06-30
General and administrative
2,126
316*
4,500
Research and development
4,656
7,715*
9,959
Total operating expenses
6,782
8,031
14,459
Operating loss
-6,782
-8,031*
-14,459
Grant income
-
-38*
25
Research and development incentive income
33
267*
127
Interest income, net
1,079
1,453*
1,075
Foreign exchange gain (loss)
7
-299*
-11
Total other income, net
1,119
1,383*
1,216
Net loss before provision for income taxes
-5,663
-
-
Income tax expense, current
18
-
-
Net loss and comprehensive loss
-5,681
-6,648
-13,243
Basic EPS
-0.06
-0.078
-0.16
Diluted EPS
-0.06
-0.078
-0.16
Basic Average Shares
89,029,458
85,198,307
85,380,587
Diluted Average Shares
89,029,458
85,198,307
85,380,587
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss and
comprehensive loss
-$5,681K
Interest income, net
$1,079K
Research and development
incentive income
$33K
Foreign exchange gain
(loss)
$7K
Net loss before
provision for income taxes
-$5,663K
Income tax expense,
current
$18K
Total other income,
net
$1,119K
Operating loss
-$6,782K
Total operating
expenses
$6,782K
Research and development
$4,656K
General and
administrative
$2,126K
Buy us a coffee
ANAVEX LIFE SCIENCES CORP. (AVXL)
ANAVEX LIFE SCIENCES CORP. (AVXL)